Kymera Therapeutics Inc (KYMR)
EBITDA Margin
-90.92%
Quarterly · Period ending:
KYMR EBITDA Margin
Latest reported-90.92%period ending
Latest reported-90.92%period ending
KYMR Quarterly EBITDA Margin (-1185.05% → -90.92%)
Quarterly ebitda margin
High-resolution chart · PNG
KYMR ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -90.9231% | |
| -195.4052% | |
| -2,977.3427% | |
| -2,895.2967% | |
| -648.5012% | |
| -287.1538% | |
| -929.2129% | |
| -1,615.6108% | |
| -156.191% | |
| -457.1498% | |
| -28.0359% | |
| -1,098.3714% | |
| -229.2194% | |
| -422.5016% | |
| -210.6016% | |
| -441.8281% | |
| -343.1562% | |
| -373.6853% | |
| -217.0998% | |
| -136.905% | |
| -130.0286% | |
| -67.1907% | |
| -95.1193% | |
| -51.3865% | |
| -412.865% | |
| -306.6219% | |
| -606.7649% | |
| -1,185.0526% |